-
Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control studyUršič-Vrščaj, Marjetka, 1952-2012 ; Rakar, StelioNeoadjuvant chemotherapy has been proposed as an alternative approach to primary cytoreductive surgery as initial management of bulky ovarian cancer with the aim of improving surgical efficiency and ... quality of life. The data ofa retrospective case-control study including 75 patients with advanced epithelial ovarian carcinoma Stages IIIC and IV are presented. In 20 patients,neoadjuvant chemotherapy (3-5 cycles of cytostatics) was applied before cytoreductive surgery which was followed by chemotherapy, six cycles intotal. In 55 patients cytoreductive surgery was applied as the primary treatment followed by six cycles of chemotherapy. A comparison of both groups of patients showed no significant difference regarding patient age, tumor stage, grade and treatment modality (chemotherapy and surgery, without irradiation) applied cytostatics and total number of chemotherapeutic cycles. The data from our study confirmed a statistically significant difference in radicality of cytoreduction that was more extensive when applied in combination with neoadjuvant chemotherapy than when applied as primary cytoreductive surgery (p = 0.009). No statistically significant difference wasfound in the survival of the two groups (p = 0.79), the response to primarytreatment (p = 0.52), relapse (p = 0.88) or disease-free survival (p = 0.61). From the findings of the study and literature review, we may conclude that neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced epithelial ovarian carcinoma does not have an unfavorable effect on the prognosis.Vir: European journal of gynaecological oncology. - ISSN 0392-2936 (Letn. 23, št. 5, 2002, str. 405-410)Vrsta gradiva - članek, sestavni delLeto - 2002Jezik - angleškiCOBISS.SI-ID - 15796697
Avtor
Uršič-Vrščaj, Marjetka, 1952-2012 |
Rakar, Stelio
Teme
Ovarian Neoplasms |
Drug Therapy |
Surgery |
Chemotherapy, Adjuvant |
Survival Analysis |
Neoplasm Staging |
Case-Control Studies |
Retrospective Studies |
Jajčnik, novotvorbe |
Kemoterapija pomožna |
Kontrolirane študije |
Novotvorba, stadij |
Preživetje, analiza |
Retrospektivne študije
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Uršič-Vrščaj, Marjetka, 1952-2012 | 09764 |
Rakar, Stelio | 02355 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.